Psychological Functioning Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Anatara Lifesciences Limited (ASX:ANR) Monthly Activities Report    Monthly Activities ReportMelbourne, July 28, 2021 AEST (ABN Newswire) - Anatara Lifesciences Limited ( ASX:ANR), a developer of evidence based solutions for gastrointestinal diseases in animals and humans, is pleased to provide this activities report for the quarter ending 30 June 2021 (Q4 FY21), along with the Company's Appendix 4C cash flow report. Commenting on the quarter, CEO Steve Lydeamore said, "Anatara is pleased to have made solid progress in obtaining the appropriate approval and grants for our human and anim...

Anatara Lifesciences Ltd (ASX:ANR) Q3 FY21 Activities Report    Q3 FY21 Activities ReportMelbourne, April 27, 2021 AEST (ABN Newswire) - Anatara Lifesciences ( ASX:ANR), a developer of non-antibiotic oral solutions for gastrointestinal diseases in animals and humans, is pleased to provide this activities report for the quarter ending 31 March 2021, along with the Company's Appendix 4C cash flow report. Commenting on the quarter, CEO Steve Lydeamore said, "Anatara is pleased to have successfully progressed two key milestones during the period - a successful trial for Anatara's proprietar...